Results about: Alumni
Researchers discover activators of a potential therapeutic target for the treatment of patients with diabetes and insulin resistance
A team headed by Antonio Zorzano at IRB Barcelona has identified activators of the mitochondrial protein Mitofusin 2 for the treatment of type 2 diabetes.
The protein is a key regulator of many mitochondrial functions, as well as of the cell as a whole.
Xavier Salvatella, ICREA researcher at IRB Barcelona, proposes a new approach to combat prostate tumour cells that have become unresponsive to the treatments currently available.
The incidence of prostate cancer is increasing worldwide. In the US and Europe, it is one of the most common tumours and among the main causes of death by cancer.
“After 10+ years at IRB, the idea of 'together we can make great things happen' is going to stick with me,” says Francisco Lozano
Many moons have passed since 2006 when Francisco Lozano (b. Madrid, 1968, better known as Curro) moved to a recently launched IRB Barcelona to head the Information Technology Services. Thanks to Curro and his team's contributions over eleven years, IRB Barcelona now boasts developed IT strategies and state-of-the-art, competitive technologies and clusters. He has recently embarked on his next career move: the International Agency for Research on Cancer (IARC) of the World Health Organization in Lyon (France) has hired him as their Head of Information Technology Services.
After spending three years as a Visiting Student in the Complex Metabolic Diseases and Mitochondria Lab led by Antonio Zorzano, Jordi Coste (b. Barcelona, 1993) is about to embark on new projects in the United States. This young scientist is leaving behind what he considers “a big family” at IRB Barcelona to pursue a career more focused on clinical counselling. But before crossing the pond, he has found time to look back on his years with us: “The Institute has helped me to improve my critical and logical thinking skills, and this will definitely help me in the future.”
The 2017 IRB Barcelona Alumni of Excellence Award has gone to Marc Liesa, who obtained his PhD in 2008 in Antonio Zorzano’s Complex Metabolic Diseases and Mitochondria Laboratory. The award, established in 2016, acknowledges the excellence of former IRB Barcelona scientists and is given with the support of Eppendorf. Liesa visited the Institute on 5 May to receive the distinction. He talks about his science and shares some secrets of his success.
Researchers led by Salvador Aznar-Benitah at IRB Barcelona investigate the role of Dnmt3a and Dnmt3b proteins in skin homeostasis and tumour development in adult mice.
The study has been published in eLife and deserved an eLife digest aimed at a more general audience.
These comprise a small group of passive stem cells—quiescent—that are activated when needed and have the capacity to produce any kind of intestinal cell.
Quiescent cells are relevant for tissue regeneration and for their participation in tumour development.